ClinicalTrials.Veeva

Menu

Effects of Emulsification and Lipid Droplet Size on Postprandial Metabolic Responses

C

Clinical Nutrition Research Centre, Singapore

Status

Completed

Conditions

Metabolic Diseases

Treatments

Other: Fine emulsion
Other: Control
Other: Coarse emulsion

Study type

Interventional

Funder types

Other

Identifiers

NCT02789683
2015/00509

Details and patient eligibility

About

The aim of this study is to compare the effects of emulsification and lipid droplet size on gastric emptying rate, and to determine if the change in gastric emptying rate can in turn influence postprandial glycemic, insulinemic and lipidemic responses.

Full description

This study will be conducted using a randomized, crossover design with three dietary phases: 1) fine emulsion beverage (small lipid droplet size), 2) coarse emulsion beverage (large lipid droplet size) and 3) non-emulsified oil and water. All treatments will be consumed together with bread. All participants will be randomly allocated to the three test meals. Fifteen to twenty participants aged between 21 and 50 years will be recruited from the general public in Singapore.

During the testing sessions, participants' glycemic, insulinemic, lipidemic responses and gastric emptying to the test meals will be measured. Gastric antral distention ultrasound measurement is an indirect measure of gastric emptying rate. Participants' metabolic satiety for the test meals will also be assessed at regular intervals throughout the testing session. Each testing session will take approximately four hours in duration and the testing sessions will take place at least five days apart.

Enrollment

20 estimated patients

Sex

Male

Ages

21 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy Chinese male subjects aged between 21 and 50 years
  • Body mass index between 20.0 to 24.9 kg/m2
  • Normal blood pressure (<140/90 mmHg)
  • Fasting blood glucose <6.0 mmol/L

Exclusion criteria

  • People with major chronic disease such as heart disease, cancer or diabetes mellitus
  • People with family history of diabetes or familial cholesterolaemic
  • People with history of liver or renal problems
  • People who have intolerances or allergies to test products
  • Individuals who are taking insulin or drugs known to affect glucose metabolism and body fat distribution
  • People with a major medical or surgical event requiring hospitalization within the preceding three months
  • Individuals with the presence of disease or drugs which influence digestion and absorption of nutrients

Trial design

20 participants in 3 patient groups

Fine emulsion
Experimental group
Description:
Emulsion with small lipid droplet size served together with white bread
Treatment:
Other: Fine emulsion
Coarse emulsion
Experimental group
Description:
Emulsion with large lipid droplet size served together with white bread
Treatment:
Other: Coarse emulsion
Control
Experimental group
Description:
Non-emulsified oil and water served together with white bread
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems